由AZ研发的AKT抑制剂Capivasertib,在10月宣布达到主要临床终点,本次会议上首次公布了这个三期临床的具体数据。 https://www.astrazeneca.com/content/dam/az/Investor_Relations/events/AstraZeneca-SABCS-2022-IR-Presentation-08-Dec-2022.pdf 该试验共入组了708例HR...
As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Swiss pharma group Roche has doubled down on a partnership with Jnana Therapeutics, paying $50 million upfront to tap into the Boston-based biotech drug discovery platform for a wide-ranging push across cancer, immune-mediated, and neurological diseases.
2022 2024 Drug Manufacturers - General Industry Comparables Screen With Investor 1-Day Chart Name Price Morningstar Rating for Stocks Capital Allocation Economic Moat Market Cap Eli Lilly and Co LLY ExemplaryWide$770.7 Bil Novo Nordisk AS ADR ...
Has four apps tailored to Core, Pathology, Molecular Labs and Point of Care Markets CE CE CE CE CE US US US EUA CE US CE US CE US Global Status RT=real time 75 Invitation to Roche Diagnostics Investor Day 2024 Innovating Diagnostics, shaping healthcare, changing lives cobas i601 mass ...
Phone: +49 172 6367262Yvette Petillon Phone: +41 79 961 92 50 Dr. Rebekka Schnell Phone: +41 79 205 27 03 Roche Investor Relations Investor Relations North America Loren Kalm Phone: +1 650 225 3217 e-mail:kalm.loren@gene.com Services Downloads...